Results 271 to 280 of about 112,335 (304)
Some of the next articles are maybe not open access.
Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemness
Cancer Drug ResistanceAim: Cancer stem cells (CSCs) are pivotal in mediating platinum resistance in ovarian cancer. This study aimed to screen compounds sensitizing CSCs to cisplatin by using a small molecule inhibitor library.
Mengqing Chen +9 more
semanticscholar +1 more source
Identification of Novel HPK1 Hit Inhibitors: From In Silico Design to In Vitro Validation
International Journal of Molecular SciencesHematopoietic progenitor kinase 1 (HPK1), a negative regulator of T-cells, B-cells, and dendritic cells, has gained attention in antitumor immunotherapy research over the past decade.
Israa H. Isawi +3 more
semanticscholar +1 more source
Thiazolidinones as Potential PGK1 Inhibitors for Treatment of Osteosarcoma Growth and Metastasis.
Journal of Medicinal ChemistryOsteosarcoma is one of the malignant bone tumors in children and adolescents. Due to unclear pathogenesis and lack of identified drug targets, there has been limited progress in developing targeted therapies in the past 50 years.
Xuwen Chen +8 more
semanticscholar +1 more source
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Targeted drug delivery strategies for precision medicines
Nature Reviews Materials, 2021Mandana T Manzari +2 more
exaly
Apoptosis-based drug screening and detection of selective toxicity to cancer cells
Anti-Cancer Drugs, 2003O. Frankfurt, A. Krishan
semanticscholar +1 more source

